OBJECTIVES: To link local proinflammatory cytokines with HIV related nucleic acids in cervico-vaginal secretions and the factors associated with them. METHODS: An observational study on 60 HIV positive women attending the department of obstetrics and gynaecology, University of Pavia, Italy. HIV-1 RNA in plasma, proviral HIV-1-DNA, cell associated and cell free HIV-1 RNA in cervico-vaginal secretions were evaluated by competitive polymerase chain reaction (c-PCR) and reverse transcriptase PCR (cRT-PCR). IL-1beta, IL-6, and TNF-alpha were measured by ELISA in cervico-vaginal lavages. Multiple regression analysis on ordinal categorical variables was used to test for the simultaneous associations of clinical and microbiological variables on quartiles of cytokine concentrations in lavage samples. RESULTS: Proviral HIV-1 DNA, cell associated and cell free HIV-1 RNA were detected in 76.7% (46/60), 70% (42/60), and 71.7% (43/60) of the patients, respectively. IL-1beta concentration was directly correlated with proviral HIV-DNA (Spearman rho = 0.35, p = 0.01) and cell associated HIV-RNA levels (Spearman rho = 0.263, p = 0.05). IL-1beta concentration (153.9 pg/ml) was higher (p<0.05) among women with cytological squamous intraepithelial lesion (SIL) than negative controls (73.4 pg/ml). In women with vaginal infection both IL-1beta (41.7 pg/ml) and IL-6 (10.2 pg/ml) were lower (p<0.05) in comparison to negative controls (144.9 pg/ml and 23.7 pg/ml, respectively). Women receiving stable antiretroviral therapy had significantly lower TNF-alpha (34.4 pg/ml versus 44.4 pg/ml, p = 0.04) and higher IL-6 (24.0 pg/ml versus 1.4 pg/ml, p = 0.004) levels in lavage samples compared to untreated women. The associations between the presence of SIL, antiretroviral treatment, vaginal infection and cytokine concentrations in cervico-vaginal secretions were confirmed in multiple regression analysis. CONCLUSIONS: Local immune activation may modulate HIV-1 shedding in cervico-vaginal secretion with possible influence on vaginal physiology and host defence. Pharmacological agents lowering HIV-1 replication cause a shift to a pattern of cytokine production which seems less favourable to the transmission of the disease.
OBJECTIVES: To link local proinflammatory cytokines with HIV related nucleic acids in cervico-vaginal secretions and the factors associated with them. METHODS: An observational study on 60 HIV positive women attending the department of obstetrics and gynaecology, University of Pavia, Italy. HIV-1 RNA in plasma, proviral HIV-1-DNA, cell associated and cell free HIV-1 RNA in cervico-vaginal secretions were evaluated by competitive polymerase chain reaction (c-PCR) and reverse transcriptase PCR (cRT-PCR). IL-1beta, IL-6, and TNF-alpha were measured by ELISA in cervico-vaginal lavages. Multiple regression analysis on ordinal categorical variables was used to test for the simultaneous associations of clinical and microbiological variables on quartiles of cytokine concentrations in lavage samples. RESULTS: Proviral HIV-1 DNA, cell associated and cell free HIV-1 RNA were detected in 76.7% (46/60), 70% (42/60), and 71.7% (43/60) of the patients, respectively. IL-1beta concentration was directly correlated with proviral HIV-DNA (Spearman rho = 0.35, p = 0.01) and cell associated HIV-RNA levels (Spearman rho = 0.263, p = 0.05). IL-1beta concentration (153.9 pg/ml) was higher (p<0.05) among women with cytological squamous intraepithelial lesion (SIL) than negative controls (73.4 pg/ml). In women with vaginal infection both IL-1beta (41.7 pg/ml) and IL-6 (10.2 pg/ml) were lower (p<0.05) in comparison to negative controls (144.9 pg/ml and 23.7 pg/ml, respectively). Women receiving stable antiretroviral therapy had significantly lower TNF-alpha (34.4 pg/ml versus 44.4 pg/ml, p = 0.04) and higher IL-6 (24.0 pg/ml versus 1.4 pg/ml, p = 0.004) levels in lavage samples compared to untreated women. The associations between the presence of SIL, antiretroviral treatment, vaginal infection and cytokine concentrations in cervico-vaginal secretions were confirmed in multiple regression analysis. CONCLUSIONS: Local immune activation may modulate HIV-1 shedding in cervico-vaginal secretion with possible influence on vaginal physiology and host defence. Pharmacological agents lowering HIV-1 replication cause a shift to a pattern of cytokine production which seems less favourable to the transmission of the disease.
Authors: S Cu-Uvin; A M Caliendo; S Reinert; A Chang; C Juliano-Remollino; T P Flanigan; K H Mayer; C C Carpenter Journal: AIDS Date: 2000-03-10 Impact factor: 4.177
Authors: L Al-Harthi; A Kovacs; R W Coombs; P S Reichelderfer; D J Wright; M H Cohen; J Cohn; S Cu-Uvin; H Watts; S Lewis; S Beckner; A Landay Journal: AIDS Date: 2001-08-17 Impact factor: 4.177
Authors: S D Lawn; S Subbarao; T C Wright; T Evans-Strickfaden; T V Ellerbrock; J L Lennox; S T Butera; C E Hart Journal: J Infect Dis Date: 2000-05-31 Impact factor: 5.226
Authors: M Debiaggi; A Spinillo; F Zara; A Santolo; R Brerra; R Maserati; E Romero; G Filice Journal: Clin Microbiol Infect Date: 1999-10 Impact factor: 8.067
Authors: A K Iversen; L Fugger; J Eugen-Olsen; U Balslev; T Jensen; S Wahl; J Gerstoft; J I Mullins; P Skinhoj Journal: J Infect Dis Date: 1998-11 Impact factor: 5.226
Authors: Deborah J Anderson; Joseph A Politch; Adam M Nadolski; Caitlin D Blaskewicz; Jeffrey Pudney; Kenneth H Mayer Journal: AIDS Date: 2010-01-16 Impact factor: 4.177
Authors: Maria L Alcaide; Violeta J Rodriguez; Megan R Brown; Suresh Pallikkuth; Kristopher Arheart; Octavio Martinez; Margaret Roach; Raina N Fichorova; Deborah L Jones; Savita Pahwa; Margaret A Fischl Journal: AIDS Res Hum Retroviruses Date: 2017-01-03 Impact factor: 2.205
Authors: Erin M Kahle; Michael Bolton; James P Hughes; Deborah Donnell; Connie Celum; Jairam R Lingappa; Allan Ronald; Craig R Cohen; Guy de Bruyn; Youyi Fong; Elly Katabira; M Juliana McElrath; Jared M Baeten Journal: J Infect Dis Date: 2014-11-10 Impact factor: 5.226
Authors: Deborah J Anderson; D'Nyce L Williams; Susan A Ballagh; Kurt Barnhart; Mitchell D Creinin; Daniel R Newman; Frederick P Bowman; Joseph A Politch; Ann C Duerr; Denise J Jamieson Journal: Am J Reprod Immunol Date: 2009-02 Impact factor: 3.886
Authors: Gregory T Spear; M Reza Zariffard; Hua Y Chen; Joshua J Anzinger; Kathryn Anastos; John Rusine; John Gatabazi; Audrey L French; Mardge Cohen; Alan L Landay Journal: AIDS Res Hum Retroviruses Date: 2008-07 Impact factor: 2.205
Authors: LaShonda Y Spencer; Shawna Christiansen; Chia-Hao H Wang; Wendy J Mack; Mary Young; Howard D Strickler; Kathryn Anastos; Howard Minkoff; Mardge Cohen; Ruth M Geenblatt; Roksana Karim; Eva Operskalski; Toni Frederick; James D Homans; Alan Landay; Andrea Kovacs Journal: J Acquir Immune Defic Syndr Date: 2016-02-01 Impact factor: 3.731
Authors: Marta E Bull; Jillian Legard; Kenneth Tapia; Bess Sorensen; Susan E Cohn; Rochelle Garcia; Sarah E Holte; Robert W Coombs; Jane E Hitti Journal: J Acquir Immune Defic Syndr Date: 2014-12-01 Impact factor: 3.731